Strong Results Lifted Merck & Co (MRK) in Q4

2 hours ago 1

Soumya Eswaran

Tue, April 7, 2026 astatine 9:21 AM CDT 3 min read

TCW funds, an concern absorption company, released its “TCW Relative Value Large Cap Fund” fourth-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. Equities ended the twelvemonth connected a affirmative note, with the S&P 500 Total Return (USD) expanding by 2.65% and achieving a singular 17.9% successful 2025. The AI assemblage continued to thrive pursuing Trump's tariff announcements. While determination are concerning indicators akin to the Dot-Com bubble, the underlying companies look to beryllium defying likelihood with technological advancements, beardown financials, and tenable valuations. The Fund (I share) returned 4.29% successful the 4th compared to 3.81% for the Russell 1000 Value Index. YTD, the Fund delivered a instrumentality of 19.32% compared to 15.91% for the Index. In addition, delight cheque the Fund’s apical 5 holdings to cognize its champion picks successful 2025.

In its fourth-quarter 2025 capitalist letter, TCW Relative Value Large Cap Fund highlighted Merck & Co., Inc. (NYSE:MRK) arsenic 1 of its starring contributors. Merck & Co., Inc. (NYSE:MRK) is simply a starring multinational healthcare institution that offers quality wellness pharmaceutical for assorted areas. On April 06, 2026, Merck & Co., Inc. (NYSE:MRK) banal closed astatine $120.85 per share. One-month instrumentality of Merck & Co., Inc. (NYSE:MRK) was -5.48%, and its shares gained 21.07% implicit the past 52 weeks. Merck & Co., Inc. (NYSE:MRK) has a marketplace capitalization of $285.83 billion.

TCW Relative Value Large Cap Fund stated the pursuing regarding Merck & Co., Inc. (NYSE:MRK) successful its 4th fourth 2025 capitalist letter:

"The champion performing stocks successful the 4th were Alphabet†, Intel (INTC; 2.69%**), and Merck & Co., Inc. (NYSE:MRK) (MRK; 2.70%**). Merck & Co. shares jumped aft the institution reported amended than expected 3rd 4th revenues. Management attributed the bushed to outgo cutting initiatives and beardown income of its pneumonia vaccine."

Why Merck & Co (MRK) Continues to Rank Among the Most Profitable Dividend Stocks

Merck & Co., Inc. (NYSE:MRK) is not connected our database of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 100 hedge money portfolios held Merck & Co., Inc. (NYSE:MRK) astatine the extremity of the 4th quarter, up from 92 successful the erstwhile quarter. While we admit the imaginable of Merck & Co., Inc. (NYSE:MRK) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

Read Entire Article